Difference between revisions of "Team:Tongji Shanghai"

 
(7 intermediate revisions by the same user not shown)
Line 82: Line 82:
 
        
 
        
 
        
 
        
−
        <div class="row">
+
 
−
      <div class="hr5" style="margin-top:55px; margin-bottom:30px;"></div>
+
−
        </div>
+
 
        
 
        
 
        
 
        
Line 90: Line 88:
 
     <div id="content">
 
     <div id="content">
 
          
 
          
−
       <!-- Start Services Section -->
+
       <!-- Start Portfolio Section -->
−
       <div class="container">
+
       <div class="project">
−
         <div class="row">
+
         <div class="container">
 +
           
 +
              <!-- Start Post -->
 +
            <div class="col-md-12">
 +
            <h2 class="classic-title"><span>Abstract</span></h2>
 +
            <div class="blog-post quote-post">
 +
              <!-- Post Content -->
 +
              <div class="post-content">
 +
                <div class="post-type">
 +
                    <img src="https://static.igem.org/mediawiki/2016/9/92/T--Tongji_Shanghai--quatation.png">
 +
                  </div>
 +
                <div class="qoute-box">
 +
                  <a>  
  
 +
<h2>We want to create a Golden Era for breast cancer patients with system OPTT (optimized photothermal therapy), a breast tumor killer.</h2>
  
−
          <!-- Start Service Icon 1 -->
+
<h2>Breast cancer is the culprit which breaks up hundreds of thousands of women’s delicate beauty and health. Photothermal therapy (PTT) has exhibited the significant potential for solid tumors treatment. However, it still has some drawbacks including off-target effect and the lack of visualization towards agent delivery.</h2>
 +
 
 +
<h2>To minimize the shortcomings, we have designed OPTT (optimized photothermal therapy), a novel treatment and report system which can achieve visualization and reduce the off-target effect of original photothermal therapy. </h2>
 +
 
 +
<h2>By combining gold nanorods with constructed plasmids, our system will open a Golden Era for breast cancer patients. Era is the acronym of “Efficiency, Reporter and Accuracy”, which generalizes the characteristics of our products. We have promoted the efficiency of photothermal therapy by constructing plasmid HTert-P53 and Hsp70-P53-luceferase to mount the thermosensitivity of tumor cells but not normal cells. With the aid of luciferase, we can observe if the tumor cells had been heat treated, which can solve the visualization problem. Beyond that, accuracy is escalated as off-target effect is diminished. The superiorities will render our system a vigorous arm to help defeat breast cancer in clinical application for the rebirth of the suffering patients in the future.
 +
</h2>
 +
 
 +
                    <div class="qoute-author">2016 iGEM Tongji Shanghai</div>
 +
                  </a>
 +
                </div>
 +
              </div>
 +
            </div>
 +
            </div>   
 +
           
 +
                      <!-- Start Service Icon 1 -->
 
           <div class="col-md-4 col-sm-4 service-box service-icon-left-more">
 
           <div class="col-md-4 col-sm-4 service-box service-icon-left-more">
 
             <div class="service-icon">
 
             <div class="service-icon">
Line 102: Line 127:
 
             <div class="service-content">
 
             <div class="service-content">
 
               <h2>Efficiency</h2>
 
               <h2>Efficiency</h2>
−
               <ul style="font-size:14px; margin-left:0px;">It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.</ul>
+
               <ul style="font-size:15px; margin-left:0px;">We have promoted the efficiency of photothermal therapy by constructing plasmid HTert-P53 and Hsp70-P53-luceferase to mount the thermosensitivity of tumor cells.</ul>
 
             </div>
 
             </div>
 
           </div>
 
           </div>
Line 113: Line 138:
 
             </div>
 
             </div>
 
             <div class="service-content">
 
             <div class="service-content">
−
               <h2>Reportability</h2>
+
               <h2>Reporter</h2>
−
             <ul style="font-size:14px; margin-left:0px;">It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.</ul>
+
             <ul style="font-size:15px; margin-left:0px;">With the aid of luciferase, we can observe if the tumor cells had been heat treated in in vivo bioluminescence imaging machine with the injection of luciferase substance.</ul>
 
             </div>
 
             </div>
 
           </div>
 
           </div>
Line 126: Line 151:
 
             <div class="service-content">
 
             <div class="service-content">
 
               <h2>Accuracy</h2>
 
               <h2>Accuracy</h2>
−
             <ul style="font-size:14px; margin-left:0px;">It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.</ul>
+
             <ul style="font-size:15px; margin-left:0px;">Beyond that, accuracy is escalated as off-target effect is diminished. The superiorities will render our system a vigorous arm to help defeat breast cancer in clinical application for the rebirth of the suffering patients in the future.</ul>
 
             </div>
 
             </div>
 
           </div>
 
           </div>
 
           <!-- End Service Icon 3 -->
 
           <!-- End Service Icon 3 -->
−
         
 
−
            <div class="row">
 
−
      <div class="hr1" style="margin-top:55px; margin-bottom:5px;"></div>
 
−
        </div>
 
−
           
 
−
        </div>
 
−
        <!-- .row -->
 
−
      </div>
 
−
      <!-- .container -->
 
−
      <!-- End Services Section -->
 
−
 
−
 
−
      <!-- Start Portfolio Section -->
 
−
      <div class="project">
 
−
        <div class="container">
 
−
           
 
−
              <!-- Start Post -->
 
−
           
 
−
            <div class="blog-post quote-post">
 
−
              <!-- Post Content -->
 
−
              <div class="post-content">
 
−
                <div class="post-type">
 
−
                    <img src="https://static.igem.org/mediawiki/2016/9/92/T--Tongji_Shanghai--quatation.png">
 
−
                  </div>
 
−
                <div class="qoute-box">
 
−
                  <a>
 
−
                      <h2 style="color: #ee3733;"><B>Abstract</B></h2>
 
−
                      <h2>Welcome to Golden Era. In this world, we’ll show you how beneficial our treatment system OPTT (optimized photothermal therapy) is as a breast tumor killer.Breast tumor, the culprit which breaks up hundreds of thousands of women’s delicate beauty and health, has become the core research point of medical specialists. Noninvasive but efficient surgery for this disease is urgently yearned for.</h2>
 
−
                      <h2>Photothermal therapy, an emerging strategy for treating solid tumors can ablate solid tumors in a noninvasive way. It has much advantages over the traditional therapy, but its efficiency and targeting effect are still not satisfactory enough.</h2>
 
−
                      <h2>To minimize the shortcomings of current therapy, we have designed OPTT (optimized photothermal therapy), a novel treatment and report system specially for breast tumor. OPTT will open a Golden Era for breast cancer patients thanks to its superiority. Golden means “gold-nanorod-mediated” and era is the abbreviation of “Efficiency, Reporter and Accuracy”, which generalizes the characteristics of our products. Hoping our system could be a vigorous arm to help defeat breast cancer in clinical application and give a rebirth to the suffering people in the future.</h2>
 
−
 
−
                    <div class="qoute-author">2016 iGEM Tongji Shanghai</div>
 
−
                  </a>
 
−
                </div>
 
−
              </div>
 
−
            </div>
 
 
              
 
              
 
               <div class="col-md-12">
 
               <div class="col-md-12">
Line 174: Line 163:
 
                     <div class="member-photo">
 
                     <div class="member-photo">
 
                         <img alt="" src="https://static.igem.org/mediawiki/2016/c/c6/T--Tongji_Shanghai--Member_individual_ZHANGJIAWEI.jpg" />
 
                         <img alt="" src="https://static.igem.org/mediawiki/2016/c/c6/T--Tongji_Shanghai--Member_individual_ZHANGJIAWEI.jpg" />
−
                         <div class="member-name">ZHANG Jiawei<span>Team Leader</span></div>
+
                         <div class="member-name">ZHANG Jiawei<span>Captain</span></div>
 
                     </div>
 
                     </div>
 
                 </div>
 
                 </div>
Line 184: Line 173:
 
                     <div class="member-photo">
 
                     <div class="member-photo">
 
                         <img alt="" src="https://static.igem.org/mediawiki/2016/e/e8/T--Tongji_Shanghai--Member_individual_WANGHONGNING.jpg" />
 
                         <img alt="" src="https://static.igem.org/mediawiki/2016/e/e8/T--Tongji_Shanghai--Member_individual_WANGHONGNING.jpg" />
−
                         <div class="member-name">WANG Will<span>Wiki Editor</span></div>
+
                         <div class="member-name">WANG Will<span>Designer</span></div>
 
                     </div>
 
                     </div>
 
                 </div>
 
                 </div>
Line 194: Line 183:
 
                     <div class="member-photo">
 
                     <div class="member-photo">
 
                         <img alt="" src="https://static.igem.org/mediawiki/2016/9/95/T--Tongji_Shanghai--Member_individual_ZHUYUMENG.jpg" />
 
                         <img alt="" src="https://static.igem.org/mediawiki/2016/9/95/T--Tongji_Shanghai--Member_individual_ZHUYUMENG.jpg" />
−
                         <div class="member-name">ZHU Yumeng<span>Team Manager</span></div>
+
                         <div class="member-name">ZHU Yumeng<span>Manager</span></div>
 
                     </div>
 
                     </div>
 
                 </div>
 
                 </div>
Line 204: Line 193:
 
                     <div class="member-photo">
 
                     <div class="member-photo">
 
                         <img alt="" src="https://static.igem.org/mediawiki/2016/8/85/T--Tongji_Shanghai--Member_individual_TANGYINGLU.jpg" />
 
                         <img alt="" src="https://static.igem.org/mediawiki/2016/8/85/T--Tongji_Shanghai--Member_individual_TANGYINGLU.jpg" />
−
                         <div class="member-name">TANG Yinglu<span>Researcher</span></div>
+
                         <div class="member-name">TANG Yinglu<span>Implementer</span></div>
 
                     </div>
 
                     </div>
 
                 </div>
 
                 </div>
Line 225: Line 214:
 
                     <div class="member-photo">
 
                     <div class="member-photo">
 
                         <img alt="" src="https://static.igem.org/mediawiki/2016/6/61/T--Tongji_Shanghai--Member_individual_ZHOUDANLEI.jpg" />
 
                         <img alt="" src="https://static.igem.org/mediawiki/2016/6/61/T--Tongji_Shanghai--Member_individual_ZHOUDANLEI.jpg" />
−
                         <div class="member-name">ZHOU Danlei<span>Researcher</span></div>
+
                         <div class="member-name">ZHOU Danlei<span>Evaluator</span></div>
 
                     </div>
 
                     </div>
 
                 </div>
 
                 </div>
Line 262: Line 251:
 
                     <div class="member-photo">
 
                     <div class="member-photo">
 
                         <img alt="" src="https://static.igem.org/mediawiki/2016/3/32/T--Tongji_Shanghai--Member_individual_WUHONGGUI.jpg" />
 
                         <img alt="" src="https://static.igem.org/mediawiki/2016/3/32/T--Tongji_Shanghai--Member_individual_WUHONGGUI.jpg" />
−
                         <div class="member-name">WU Honggui<span>Researcher</span></div>
+
                         <div class="member-name">WU Honggui<span>Idea Seeker</span></div>
 
                     </div>
 
                     </div>
 
                 </div>
 
                 </div>
Line 273: Line 262:
 
                     <div class="member-photo">
 
                     <div class="member-photo">
 
                         <img alt="" src="https://static.igem.org/mediawiki/2016/7/76/T--Tongji_Shanghai--Member_individual_ZHUYAJIE.jpg" />
 
                         <img alt="" src="https://static.igem.org/mediawiki/2016/7/76/T--Tongji_Shanghai--Member_individual_ZHUYAJIE.jpg" />
−
                         <div class="member-name">ZHU Yajie<span>Researcher</span></div>
+
                         <div class="member-name">ZHU Yajie<span>Coordinator</span></div>
 
                     </div>
 
                     </div>
 
                 </div>
 
                 </div>
Line 286: Line 275:
 
                     <div class="member-photo">
 
                     <div class="member-photo">
 
                         <img alt="" src="https://static.igem.org/mediawiki/2016/9/99/T--Tongji_Shanghai--Member_individual_RENQIAN.jpg" />
 
                         <img alt="" src="https://static.igem.org/mediawiki/2016/9/99/T--Tongji_Shanghai--Member_individual_RENQIAN.jpg" />
−
                         <div class="member-name">REN Qian<span>Researcher</span></div>
+
                         <div class="member-name">REN Qian<span>Implementer</span></div>
 
                     </div>
 
                     </div>
 
                 </div>
 
                 </div>
Line 296: Line 285:
 
                     <div class="member-photo">
 
                     <div class="member-photo">
 
                         <img alt="" src="https://static.igem.org/mediawiki/2016/0/00/T--Tongji_Shanghai--Member_individual_XUCHENRUI.jpg" />
 
                         <img alt="" src="https://static.igem.org/mediawiki/2016/0/00/T--Tongji_Shanghai--Member_individual_XUCHENRUI.jpg" />
−
                         <div class="member-name">XU Chenrui<span>Wiki editor</span></div>
+
                         <div class="member-name">XU Chenrui<span>Specialist</span></div>
 
                     </div>
 
                     </div>
 
                 </div>
 
                 </div>

Latest revision as of 05:48, 19 October 2016

Tongji_Shanghai-2016.igem.org Tongji Shanghai

Abstract

We want to create a Golden Era for breast cancer patients with system OPTT (optimized photothermal therapy), a breast tumor killer.

Breast cancer is the culprit which breaks up hundreds of thousands of women’s delicate beauty and health. Photothermal therapy (PTT) has exhibited the significant potential for solid tumors treatment. However, it still has some drawbacks including off-target effect and the lack of visualization towards agent delivery.

To minimize the shortcomings, we have designed OPTT (optimized photothermal therapy), a novel treatment and report system which can achieve visualization and reduce the off-target effect of original photothermal therapy.

By combining gold nanorods with constructed plasmids, our system will open a Golden Era for breast cancer patients. Era is the acronym of “Efficiency, Reporter and Accuracy”, which generalizes the characteristics of our products. We have promoted the efficiency of photothermal therapy by constructing plasmid HTert-P53 and Hsp70-P53-luceferase to mount the thermosensitivity of tumor cells but not normal cells. With the aid of luciferase, we can observe if the tumor cells had been heat treated, which can solve the visualization problem. Beyond that, accuracy is escalated as off-target effect is diminished. The superiorities will render our system a vigorous arm to help defeat breast cancer in clinical application for the rebirth of the suffering patients in the future.

2016 iGEM Tongji Shanghai

Efficiency

    We have promoted the efficiency of photothermal therapy by constructing plasmid HTert-P53 and Hsp70-P53-luceferase to mount the thermosensitivity of tumor cells.

Reporter

    With the aid of luciferase, we can observe if the tumor cells had been heat treated in in vivo bioluminescence imaging machine with the injection of luciferase substance.

Accuracy

    Beyond that, accuracy is escalated as off-target effect is diminished. The superiorities will render our system a vigorous arm to help defeat breast cancer in clinical application for the rebirth of the suffering patients in the future.

Meet Our Team

ZHANG JiaweiCaptain
WANG WillDesigner
ZHU YumengManager
TANG YingluImplementer
ZHOU XingyuResearcher
ZHOU DanleiEvaluator
LYU TongResearcher
HU ZhangsenResearcher
WU HongguiIdea Seeker
ZHU YajieCoordinator
REN QianImplementer
XU ChenruiSpecialist